Inmode Ltd Equity-NMS: INMD

Healthcare

Medical Devices

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$36.04

52W high :

$99.27

1Y :

-65.65%

5Y :

143.79%

EPS(TTM): :

1.92

Shares O/S :

83.24 M

Market cap :

3.08 B

What is the share price of Inmode Ltd today?

Inmode Ltd (INMD) share price as of August 12, 2022, is $36.98. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Inmode Ltd?

Yes, Indian Investors can invest in the Inmode Ltd (INMD) Share by opening an international trading account with Angel One.

How can I purchase Inmode Ltd shares in India?

Purchasing Inmode Ltd (INMD) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Inmode Ltd (INMD) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Inmode Ltd?

Yes, you can purchase fractional shares of Inmode Ltd (INMD) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Inmode Ltd?

The market capitalization of Inmode Ltd on August 14, 2022, is $3.08 B.

In which sector Inmode Ltd belongs?

Inmode Ltd operates in the Healthcare sector, specifically in the Medical Devices industry.

What documents are required to invest in Inmode Ltd stocks?

In order to invest in Inmode Ltd (INMD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. It owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.